Table 3.
Meta-analyses with clinical trial studies compared to the control group.
| Outcome | No. of Studies [Reference] |
MD (95% CI) | Heterogeneity I2 % |
|---|---|---|---|
| Weight | 9 [31,33,37,38,39,40,43,44,45] |
−0.38 (−1.20, 0.29) | 0% |
| Body composition | |||
| Fat percent | 4 [31,38,39,44] |
−0.55 (−1.15, 0.05) | 0% |
| Fat mass | 6 [31,33,37,39,40,41] |
−1.27 (−1.96, −0.59) | 0% |
| Fat-free mass | 7 [31,33,37,38,39,40,41] |
0.07 (−0.70, 0.84) | 0% |
| Fasting glucose concentration | 9 [30,31,33,36,37,41,43,44,45] |
−0.96 (−4.26, 2.33) | 77.4% |
| Lipid profile | |||
| Triglycerides | 9 [28,30,31,33,36,37,40,41,45] |
−8.79 (−24.27, 6.90) | 80.3% |
| LDL cholesterol | 10 [28,30,31,33,36,37,40,41,44,45] |
−1.05 (−8.94, 6.87) | 65.9% |
| HDL cholesterol | 10 [28,30,31,33,36,37,40,41,44,45] |
2.55 (−1.44, 6.54) | 71.1% |